Today, we've recommended capivasertib (also called Truqap and made by AstraZeneca) with fulvestrant as an option for around 1,100 adults with hormone receptor (HR)-positive HER2-negative breast cancer ...

A new drug that helps slow the spread of an incurable type of breast cancer has been approved for use in Britain’s state-run ...

Capivasertib is taken as a twice-daily pill, in combination with the hormone therapy fulvestrant. The drug works by blocking ...

There will be about 299,010 new cases of prostate cancer diagnosed this year, according to the American Cancer Society.

Michelle Xia represents a rising generation of biotech companies in China challenging Western giants.